Hongcheng Sun

Title: Innovations of Hongcheng Sun in Protein Hydrogel Technology

Introduction

Hongcheng Sun is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of biomedical materials, particularly in the development of innovative hydrogels. His work focuses on enhancing drug delivery systems, which can have a profound impact on cancer treatment.

Latest Patents

One of Hongcheng Sun's key patents is for a cis-platinum cross-linked protein hydrogel and its preparation method. This invention involves a hydrogel that comprises 0.5% to 5.0% drug, 6.0% to 50.0% serum albumin, and 47.0% to 93.0% solvent medium. The unique feature of this hydrogel is that a carboxyl group on the surface of the serum albumin forms a coordinate bond with the drug, which is cis-platinum. This dual-functionality allows cis-platinum to act both as a cross-linking agent and an antitumor drug, simplifying the carrier design while reducing potential toxic side effects. The protein carboxyl also limits the release of cis-platinum, significantly decreasing the burst release of the loaded drugs.

Career Highlights

Hongcheng Sun is affiliated with Hangzhou Normal University, where he conducts research and develops innovative solutions in the field of hydrogels. His work has garnered attention for its potential applications in medical treatments, particularly in oncology.

Collaborations

Hongcheng Sun collaborates with esteemed colleagues such as Shuangjiang Yu and An Yan. Their combined expertise contributes to advancing research in the field of protein hydrogels and drug delivery systems.

Conclusion

Hongcheng Sun's innovative work in the development of cis-platinum cross-linked protein hydrogels represents a significant advancement in drug delivery technology. His contributions have the potential to improve treatment outcomes for cancer patients, showcasing the importance of innovation in the medical field.